Serum 2-hydroxyestradiol 17-sulphate in pregnancy

Citation
T. Kashiwagi et al., Serum 2-hydroxyestradiol 17-sulphate in pregnancy, ENDOCR J, 46(3), 1999, pp. 453-458
Citations number
11
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
ENDOCRINE JOURNAL
ISSN journal
09188959 → ACNP
Volume
46
Issue
3
Year of publication
1999
Pages
453 - 458
Database
ISI
SICI code
0918-8959(199906)46:3<453:S21IP>2.0.ZU;2-E
Abstract
2-Hydroxyestradiol 17-sulphate (2-OH E-2-17-S) is a catecholized form of su lphated estrogen. In vitro studies showed that its antioxidative effect is almost equal to that of free catecholestrogens, such as 2-OH E-2 or 4-OH E- 2 and alpha-tocoferol, but the existance of 2-OH E-2-17-S in human serum ha s not yet been made clear. 2-OH E-2-17-S strongly antagonizes lipid peroxid ation, and so it may play an important role in pregnancy, for example as an anti-oxidant in pregnancy-induced hypertension (PIH). The serum level of 2 -OH E-2-17-S was measured during mid to late pregnancy by a direct radioimm unoassay (RIA) without hydrolysis. The serum levels at 28-31 weeks, 32-35 w eeks and 36-40 weeks of gestation were 4.68+/-0.93 (mean+/-SE), 8.38+/-1.21 and 18.31+/-3.41 nmol/l, respectively. The serum level in PIH cases at 36- 40 weeks (4.64+/-1.29 nmol/l) was significantly lower than that in normal p regnancy. The 2-OH E-2-17-S level in umbilical arteries was significantly h igher than that in maternal peripheral vein. These results suggest that the fete-placental unit plays an important role in catecholizing E-2-17-S to 2 -OH E-2-17-S, which may act as an antioxidant in pregnancy.